Investment ThemesDetailed Quotes
Weight Loss Drugs
Watchlist
GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
- 1713.140
- -12.668-0.73%
Close Nov 1 16:00 ET
1732.391High1710.558Low
1727.031Open1725.808Pre Close64.52MVolume1Rise62.01P/E (Static)7.03BTurnover1Flatline0.61%Turnover Ratio1.62TMarket Cap5Fall1.47TFloat Cap
Constituent Stocks: 7Top Rising: VKTX+0.47%
👇🏻🔬🔬🔬
Thanks to Wall Street, Novo Nordisk Stock is Now a Buy
Meta, Microsoft and Nvidia all fell more than 4% - a rare scene that you don’t see often.
I guess the potential and promises of AI are not enough. Investors want solid returns from AI investment.
$Hilton Worldwide (HLT.US)$ $Wells Fargo & Co (WFC.US)$ $Target (TGT.US)$ $Peloton Interactive (PTON.US)$ $Fullerton SGD Cash Fund (SG9999005961.MF)$ $Pfizer (PFE.US)$ ...
Eli Lilly lowered guidance on lackluster sales of its blockbuster weight-loss drug Zepbound and diabetes drug Mounjaro.
(watch this Bloomberg video - Gameover!)
*********
Let me say this. If LLY stock was to go up, you might get a maximum of $200 in the next 3 months. If it drops, it's going under $500. Remember this is all my opinion, do you own research. Just look at the chart. Also, if you see so many analysts trying to pump the stock, ...
No comment yet